Susan Kornstein
Psychiatry · Richmond, VANPI 1528149846
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $52,115 of the $74,017 with a category attached, or 70.4%. It is spread thinly across 12 manufacturers, the largest accounting for just 22.8%. Reporting peaked in 2019 at $45,613 and has fallen 77.7% since, to $10,150 in 2025. Among psychiatry clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 140 payments — averaging $528.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$17K
- Johnson & Johnson$11K
- Acadia Pharmaceuticals Inc$10K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$10K
- Sunovion Pharmaceuticals Inc.$9K
- AbbVie$8K
- plus $9K from 6 others
Across 5 payments — averaging $2532.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$13K
What the payments were for
- Consulting fees$52,11570%
- Speaking & faculty fees$7,25010%
- Travel & lodging$11,68316%
- Food & beverage$2,9694%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 25 | $16,844 |
| Johnson & Johnson | 20 | $10,510 |
| Acadia Pharmaceuticals Inc | 19 | $10,182 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $10,170 |
| Sunovion Pharmaceuticals Inc. | 14 | $8,687 |
| AbbVie(2 entities) | 24 | $8,459 |
| Eli Lilly | 4 | $4,938 |
| Biogen | 1 | $2,658 |
| Alkermes, Inc. | 3 | $1,196 |
| Teva Pharmaceuticals USA, Inc. | 3 | $150 |
| Novo Nordisk | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$74,017 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 19 | $1,345 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Richmond
- Ashvin PatelRichmond$68K
- James SellmanRichmond$18K
- Frederick MoellerRichmond$16K
- Robert SewardRichmond$14K
- William KernodleRichmond$14K
- John LeeRichmond$10K
- Tamar CarmelRichmond$8K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Kent McDanielGlen Allen$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.